These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30850577)

  • 1. CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1.
    Yi G; Mandoli A; Jussen L; Tijchon E; van Bergen MGJM; Cordonnier G; Hansen M; Kim B; Nguyen LN; Jansen PWTC; Vermeulen M; van der Reijden B; van den Akker E; Bond J; Martens JHA
    Blood Cancer J; 2019 Mar; 9(3):33. PubMed ID: 30850577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia.
    Mandoli A; Singh AA; Jansen PW; Wierenga AT; Riahi H; Franci G; Prange K; Saeed S; Vellenga E; Vermeulen M; Stunnenberg HG; Martens JH
    Leukemia; 2014 Apr; 28(4):770-8. PubMed ID: 24002588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.
    Kuvardina ON; Herglotz J; Kolodziej S; Kohrs N; Herkt S; Wojcik B; Oellerich T; Corso J; Behrens K; Kumar A; Hussong H; Urlaub H; Koch J; Serve H; Bonig H; Stocking C; Rieger MA; Lausen J
    Blood; 2015 Jun; 125(23):3570-9. PubMed ID: 25911237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
    Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
    Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
    Wang S; Liu Y; Zhao X; Wang X; Lou J; Jin P; Zhang Y; Yu J; Wang K
    Br J Haematol; 2024 Aug; 205(2):552-567. PubMed ID: 38802066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
    Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
    Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
    Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.
    Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK
    Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.
    Zhang W; Wang H; Zhang P; Li H; Ma X; Liu H
    Braz J Med Biol Res; 2021; 54(12):e11605. PubMed ID: 34730684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
    Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP
    Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.
    Pimkin M; Kossenkov AV; Mishra T; Morrissey CS; Wu W; Keller CA; Blobel GA; Lee D; Beer MA; Hardison RC; Weiss MJ
    Genome Res; 2014 Dec; 24(12):1932-44. PubMed ID: 25319996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
    Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
    Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.
    Richter L; Wang Y; Hyde RK
    Oncotarget; 2016 Oct; 7(40):66255-66266. PubMed ID: 27542261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
    Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.